title: WHO consensus statement.
authors.forename: M A
authors.initials: MA
authors.lastname: Abas
authors.forename: S W
authors.initials: SW
authors.lastname: Acuda
authors.forename: J C
authors.initials: JC
authors.lastname: Broadhead
authors.forename: I V
authors.initials: IV
authors.lastname: Chagwedera
authors.forename: F B
authors.initials: FB
authors.lastname: Chikara
authors.forename: J M
authors.initials: JM
authors.lastname: Piachaud
authors.forename: M
authors.initials: M
authors.lastname: Stefanovio
authors.forename: J
authors.initials: J
authors.lastname: Vermeulen
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy*; D006801:Humans; D010276:Parasympatholytics / Q000627:therapeutic use*
chemical_list: D014150:Antipsychotic Agents; D010276:Parasympatholytics